SBC Medical Group Holdings Incorporated (SBC) 주식 분석

회사 개요

SBC Medical Group Holdings Incorporated operates as a provider of management services to cosmetic treatment centers across Japan, Vietnam, the United States, and Singapore, delivering advertising, marketing, and staff management solutions through its subsidiaries. The company functions within the Industrials sector, specifically classified under the Consulting Services industry, which positions it as an intermediary offering specialized operational expertise rather than direct product sales. Its current market capitalization stands at $445.18M, supported by an annual revenue of $173.61M and a workforce of 863 employees. These valuation and revenue figures indicate that SBC maintains a mid-cap profile with a consolidated revenue base that supports a significant operational footprint in the global aesthetic medicine market.

재무 건전성

The company reported a Total Revenue of $173.61M for the trailing twelve months, generating a Net Income of $50.99M and an EBITDA of $70.17M, which highlights a substantial gap between gross earnings and net profit attributable to operating expenses and taxes. The Free Cash Flow stands at $25.41M, demonstrating that the company generates sufficient cash to cover capital expenditures and operational costs, thereby ensuring financial flexibility for potential strategic investments or debt reduction. Margin analysis reveals a Gross Margin of 73.3%, an Operating Margin of 32.5%, and a Profit Margin of 29.4%, indicating a highly efficient cost structure where high pricing power or low cost of goods sold is preserved through effective operational leverage. Liquidity is robust with Total Cash at $164.09M significantly outweighing Total Debt of $51.64M, while a Debt to Equity ratio of 19.61 reflects a highly conservative balance sheet with minimal leverage relative to shareholder equity. Short-term liquidity is further confirmed by a Current Ratio of 3.78, signaling that the company holds ample current assets to cover its short-term liabilities without strain. Management effectiveness is evidenced by a Return on Equity of 22.3% and a Return on Assets of 13.0%, metrics that suggest the firm utilizes shareholder capital and total assets efficiently to generate returns above industry averages.

밸류에이션 평가

Valuation metrics indicate a Trailing P/E of 8.68 and a Forward P/E of 8.68, suggesting that the market expects earnings stability rather than significant acceleration or deceleration in the near term. The Price to Book ratio is 1.79, implying that the stock trades at a modest premium of roughly 79% over its tangible book value, reflecting intangible assets or growth expectations not captured on the balance sheet. Alternative valuation measures include a Price to Sales ratio of 2.56 and an EV/EBITDA of 4.96, which suggest the company is valued at less than three times its revenue and under five times its earnings before interest, taxes, depreciation, and amortization. The 52-week trading range spans from a low of $2.97 to a high of $5.75, providing a historical volatility context for price analysis. The Beta value is recorded at 0.99, indicating that the stock's price volatility generally mirrors the broader market movements without exhibiting significant systematic risk amplification or dampening.

Growth & Income

Revenue growth for the year-over-year period was -10.9%, while Earnings Growth for the same period surged to 117.5%, demonstrating a scenario where profitability expanded significantly despite a contraction in top-line sales, likely driven by margin expansion or cost restructuring. The company does not pay dividends, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, which means the firm retains all earnings to fuel reinvestment rather than distributing income to shareholders. This retention strategy supports the overall growth and income profile where capital is prioritized for internal expansion or operational improvements rather than immediate shareholder returns. Consequently, the company presents a growth-oriented capital allocation model typical of firms in the consulting services sector that prioritize scaling operations over dividend distributions.